Advertisement
Screener

HOOKIPA PHARMA INC. Cash and Cash Equivalents

HOOKIPA PHARMA INC. Cash and Cash Equivalents

HOOKIPA PHARMA INC. had Cash and Cash Equivalents of $40.28 million as of 2025-03-31, per its 10-Q filed 2025-05-15.

Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments

us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2025-05-15

  • 2025-03-31: Cash and Cash Equivalents, at Carrying Value $40.28M.
  • 2024-12-31: Cash and Cash Equivalents, at Carrying Value $39.68M.
  • 2024-09-30: Cash and Cash Equivalents, at Carrying Value $59.75M.
  • 2024-06-30: Cash and Cash Equivalents, at Carrying Value $77.15M.
Period endCash and Cash Equivalents, at Carrying Value
2025-03-31$40.28M
10-Q · filed 2025-05-15
2024-12-31$39.68M
10-Q · filed 2025-05-15
2024-09-30$59.75M
10-Q · filed 2024-11-14
2024-06-30$77.15M
10-Q · filed 2024-08-08
2024-03-31$92.75M
10-Q · filed 2024-05-09
2023-12-31$117.10M
10-K · filed 2025-02-28
2023-09-30$107.68M
10-Q · filed 2023-11-09
2023-06-30$135.59M
10-Q · filed 2023-08-10
2023-03-31$109.60M
10-Q · filed 2023-05-11
2022-12-31$112.49M
10-K · filed 2024-03-22
2022-09-30$99.78M
10-Q · filed 2022-11-14
2022-06-30$117.92M
10-Q · filed 2022-08-11
2022-03-31$140.82M
10-Q · filed 2022-05-16
2021-12-31$65.92M
10-K · filed 2023-03-15
2021-09-30$82.27M
10-Q · filed 2021-11-10
2021-06-30$102.52M
10-Q · filed 2021-08-12
2021-03-31$127.72M
10-Q · filed 2021-05-12
2020-12-31$142.74M
10-K · filed 2022-03-24
2020-09-30$81.83M
10-Q · filed 2020-11-12
2020-06-30$92.86M
10-Q · filed 2020-08-13
2020-03-31$104.45M
10-Q · filed 2020-05-14
2019-12-31$113.15M
10-K · filed 2021-03-18
2019-09-30$123.69M
10-Q · filed 2019-11-12
2019-06-30$134.89M
10-Q · filed 2019-08-12
2019-03-31$70.51M
10-Q · filed 2019-05-20
2018-12-31$48.58M
10-K · filed 2020-03-19
2018-03-31$64.76M
10-Q · filed 2019-05-20
2017-12-31$61.36M
10-Q · filed 2019-05-20